Sector: Pharmaceuticals & Biotechnology

Large Cap

Neuland Laboratories Share Price

NEULANDLAB

₹19,478

-64.00(-0.33%)

10th Jul 2026 | 3:28 PM

NSE : NEULANDLAB

Open Free Demat Account

Neuland Laboratories Performance

Price Movement

₹19478.00

₹19353.00

₹19730.00

↘ Today's Low↗ Today's High

1 Year Performance

₹19478.00

₹11500.00

₹20089.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹19,730.00

Low₹19,353.00

Open at₹19,701.00

Prev Close₹19,542.00

Volumes24.86 K

Avg Price₹19,521.86

Lower Circuit₹15,634.00

Upper Circuit₹23,450.00

Historical Performance

3M High₹20,089.00

3M Low₹14,283.00

1 Yr High₹20,089.00

1 Yr Low₹11,500.00

3 Yr High₹20,089.00

3 Yr Low₹2,870.10

5 Yr High₹20,089.00

5 Yr Low₹967.00

Summary

As of 10-07-2026 20:26, Neuland Laboratories Ltd. share price today is ₹0, with a change of ₹-19542.00 (-100.00%) from the previous close of ₹19542. The stock opened at ₹19701 and traded between ₹19353 and ₹19730, with a total traded volume of 24863 shares. The company has a market capitalization of ₹25072.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹20089 and ₹11500, respectively.

Neuland Laboratories Ltd. valuation metrics include a P/E ratio of 68.9, EPS of ₹283.71, and book value of ₹13.40. Profitability indicators show ROE of 19.41% along with a dividend yield of 0.1%. Neuland Laboratories Ltd. has reported revenue of ₹2022.99 Cr and net profit of ₹364 Cr.

Neuland Laboratories Ltd. technical indicators include Day RSI at 78.12, Day MFI at 85.78, Day ADX at 33.01. Additional indicators include Commodity Channel Index (CCI) at 131.2 and Williams %R at -17.77. Momentum indicators show Day MACD at 647.46, Day MACD Signal Line at 557.67, DayATR at 624.8. Rate of Change indicators for Neuland Laboratories Ltd. include ROC125 at 27.93 and ROC21 at 13.7.

Exponential moving averages include EMA5 at ₹19074.4, EMA10 at ₹18753.7, EMA12 at ₹18635.9, EMA20 at ₹18238.6, EMA26 at ₹17988.4, EMA50 at ₹17158.6, EMA100 at ₹16160, EMA200 at ₹15278.9. Simple moving averages include SMA5 at ₹19046.2, SMA10 at ₹18763.3, SMA20 at ₹18028, SMA30 at ₹17676.3, SMA50 at ₹17199.5, SMA100 at ₹15249.1, SMA150 at ₹15121.6, SMA200 at ₹15395.6.

Support levels for Neuland Laboratories are placed at First Support ₹18938.33, Second Support ₹18334.67, Third Support ₹17759.33. Resistance levels are seen at First Resistance ₹20117.33, Second Resistance ₹20692.67, Third Resistance ₹21296.33. Neuland Laboratories Ltd. shareholding pattern shows promoter holding at 32.63%, FII holding at 20.46%, DII holding at 0%, public holding at 31.08%.

Neuland Laboratories Fundamentals

Market Cap

High in industry

25,072.20 Cr.

PE Ratio (TTM)

High in industry

68.90

Dividend Yield

Low in industry

0.10

Net Profit TTM

39.9% incr over last year

364

Net Profit Growth

39.9% incr over last year

364

PEG Ratio

High in industry

1.70

ROE

13.8% incr over last year

19.41

Operating Revenue TTM

2,022.99

Operating Revenue Growth

37.0% incr over last year

Book Value

High in industry

13.40

MFI

MFI strongly Overbought

85.78

RSI

RSI Overbought

78.12

EPS (TTM)

283.71

Debt to Equity

0.10

Face Value

Operating Profit Margin Qtr.

27.98

Operating Profit Qtr.

307.33

Net Profit Qtr.

212.67

Operating Revenue Qtr.

776.25

PB Ratio

13.40

Neuland Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	776.25	439.71	514.27	292.75	328.36
Operating Expense	469.35	362.78	359.15	258.46	277.61
Operating Profit	306.90	76.93	155.12	34.29	50.75
Depreciation	25.09	23.92	22.54	20.19	16.89
Interest	7.23	6.79	5.34	4.58	2.35
Tax	74.52	13.86	32.58	3.67	11.25
Net Profit	212.52	40.42	96.46	13.71	27.73

Neuland Laboratories Technicals

Neuland Laboratories Ltd. EMA & SMA

₹19478.00

589.00 (3.12%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹19074.4

Day EMA10 ₹18753.7

Day EMA12 ₹18635.9

Day EMA20 ₹18238.6

Day EMA26 ₹17988.4

Day EMA50 ₹17158.6

Day EMA100 ₹16160

Day EMA200 ₹15278.9

Neuland Laboratories Support and Resistance

Resistance

First Resistance₹20117.33

Second Resistance₹20692.67

Third Resistance₹21296.33

Support

First Support₹18938.33

Second Support₹18334.67

Third Support₹17759.33

Technical Indicators

Day RSI78.12

Day MFI85.78

Day ADX33.01

Day Commodity Channel Index131.20

William-17.77

Day MACD647.46

Day MACD Signal Line557.67

Day ATR624.80

Day ROC12527.93

Day ROC2113.70

Neuland Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	32.7	32.7	32.7	32.6	32.6	32.6
FII	23.9	22.1	21.7	20.6	20.9	20.5
DII	9.5	11.4	12	14	14.7	15.8
Public	34	33.8	33.7	32.8	31.8	31.1

Neuland Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	35.56 K	1.01 L	35.20%
Week	34.23 K	68.23 K	50.17%
1 Month	24.67 K	56.45 K	43.70%
6 Month	20.37 K	56.24 K	36.21%

Neuland Laboratories SWOT Analysis

Strengths29

Weakness9

Opportunity6

Threats0

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Strong QoQ EPS Growth in recent results

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Negative to Positive growth in Sales and Profit with Strong Price momentum

High Volume, High Gain

Top Gainers

New 52 Week High

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Neuland Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
24 Jul, 2026	34	FINAL	24 Jul, 2026	Equity Share
18 Jul, 2025	12	FINAL	18 Jul, 2025	Equity Share
12 Jul, 2024	14	FINAL		Equity Share
11 Jul, 2023	10	FINAL		Equity Share
14 Jul, 2022	5	FINAL	15 Jul, 2022	Equity Share
29 Jun, 2021	3	FINAL		Equity Share
10 Nov, 2020	2	INTERIM	11 Nov, 2020	Equity Share
18 Feb, 2020	2	INTERIM	20 Feb, 2020	Equity Share
27 Jun, 2019	1.2	FINAL		Equity Share
04 Aug, 2016	2	FINAL		Equity Share

Neuland Laboratories Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹754.95	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	0.39%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,124.33	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹591.79	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	71.60	75.10	37.10	54.70	-70.30
1 Year Return	190.14	31.93	57.98	43.82	0.21	-14.62
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on NEULANDLAB

What is the current share price of Neuland Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Neuland Laboratories Ltd. is ₹ 19478 on the NSE and ₹ 19551.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Neuland Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Neuland Laboratories Ltd. is approximately ₹ 25072.2 Cr.

What are the PE and PB ratios for Neuland Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Neuland Laboratories Ltd. is 68.9, and the Price-to-Book (PB) ratio is 13.4.

What is the 52-Week High and Low for Neuland Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Neuland Laboratories Ltd. shares was ₹ 20089, and the lowest price was ₹ 11500.

What is the current dividend yield for Neuland Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Neuland Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Neuland Laboratories Ltd.?

Significant shareholdings in Neuland Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Neuland Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Neuland Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Neuland Laboratories Ltd.?

Neuland Laboratories Ltd. last declared a FINAL dividend of ₹ 34 per share for the financial period ending 2026. The record date was set as 2026-07-24, and the payment was/is scheduled around 2026-07-24. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy